CD19 and stroke disorder: Fittingly, a study of tMCAo stroke in mice, showed a significant autoimmune response to brain antigens at 4 days through 10 days after stroke, determined by an increase in autoreactive CD4+ and CD8+ T cells and CD19+ B cells, isolated from spleens and cervical lymph nodes (46).